Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Lilly to invest US$ 6 bn in new API plant in Alabama; Biocon buys remaining stake in Biocon Biologics, makes it 100% subsidiary

In this week’s Phispers, Eli Lilly announced yet another investment in the US — this time to build its largest API ...

Impressions : 576

Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs

In Phispers this week, Eli Lilly reduced prices of its obesity drug Zepbound sold through LillyDirect, aiming to expand access...

Impressions : 897

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

In Phispers this week, Eli Lilly became the first pharmaceutical company to reach a market valuation of US$ 1 trillion, driven ...

Impressions : 1350

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

In this week’s Phispers, Merck struck a US$ 9.2 billion deal to acquire Cidara Therapeutics to strengthen its infectious-...

Impressions : 744

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Lilly to invest US$ 6 bn in new API plant in Alabama; Biocon buys remaining stake in Biocon Biologics, makes it 100% subsidiary

Lilly cuts price of Zepbound; leaked memo on child deaths due to Covid vaccines triggers reaction from former FDA chiefs

Lilly becomes first pharma to hit US$ 1 tn valuation; FDA clears Padcev-Keytruda combo for bladder cancer

Merck to buy Cidara for US$ 9.2 bn to strengthen infectious disease portfolio; J&J to acquire Halda for US$ 3.05 bn

Caplin's Generics Acetaminophen Receives Approval in US

Mylan's Generics Macitentan Receives Approval in US

MSN's Generics Brivaracetam Receives Tentative Approval in US

Mankind's Generics Sugammadex Receives Tentative Approval in US

Amneal's Generics Albuterol Sulfate Receives Approval in US

Otsuka Pharm's Biologics Voyxact Receives Approval in US

Zydus' Generics Verapamil HCl Receives Approval in US

Alembic Pharms' Generics Dapagliflozin Receives Approval in US

Micro's Generics Olmesartan Medoxomil Receives Approval in US

Apotex's Ruxolitinib Receives Approval in US

CDL Services' Receives FDA Warning Letter

DeVere Manufacturing's Receives FDA Warning Letter

Ningxia Taiyicin Biotech's Fails EDQM inspection

Rhyz Analytical's Receives FDA Warning Letter

Turbare Manufacturing's Receives FDA Warning Letter

FDA Issues Form 483 to North American Custom Laboratories

Wells Pharma of Houston's Receives FDA Warning Letter

Owen Bio's Receives FDA Warning Letter

FDA Issues Form 483 to Fareva Amboise

FDA Issues Form 483 to Immacule Lifesciences

FDA Approves AKEEGA For BRCA2-Mutated Prostate Cancer

Indoco Remedies Receives USFDA EIR For Patalganga API Facility

Himachal Drug Cos Under Stop Orders Found Operational

Emergent Biosolutions Gets FDA Nod For Raxibacumab Production

Dominari Holdings Adjusts Record And Payment Dates For $10M Cash

Delhi HC Denies Stay On Dr. Reddy's Export Of Semaglutide

Arcus Updates Phase 3 STAR-221 Study, Focuses R&D On Casdatifan

Zealand Pharma, OTR Therapeutics Ink Metabolic Collaboration

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Lindus & Quotient Accelerate Drug Dev from FIH to Pivotal Trials

Shilpa Pharma Gets EU Approval For Rotigotine Transdermal Patch

Senores Pharma Introduces Deferiprone Tablets USP In US

Glenmark Pharma USA To Launch Leucovorin Calcium Injection

Glenmark To Launch Generic Medication In US

Civica To Supply Generic Medicines under Contract Awarded

FDA Approves Alembic's Loteprednol-Tobramycin Eye Drops

Indian drugmaker Zee Laboratories promises cheap alternatives

Teva Moves To Delist 200-Plus Patents From FDA Registry: FTC

Teva Submits FDA Application For Olanzapine Injectable

Caplin Steriles Secures FDA Approval For Acetaminophen Injection

FDA Approves AKEEGA For BRCA2-Mutated Prostate Cancer

Emergent Biosolutions Gets FDA Nod For Raxibacumab Production

Arcus Updates Phase 3 STAR-221 Study, Focuses R&D On Casdatifan

Zealand Pharma, OTR Therapeutics Ink Metabolic Collaboration

Lilly's obesity triple threat tops phase 3 efficacy forecasts

Lindus & Quotient Accelerate Drug Dev from FIH to Pivotal Trials

Zelluna Finishes Initial GMP Batch Of ZI-MA4-1, TCR-NK Cell Trial

Lilly's Inluriyo Shows Reinforced Efficacy in Breast Cancer

Tiziana Life Sciences Initiates Phase 2 Alzheimer's Trial Dosing

Tenaya Therapeutics Announces Pricing Of Public Offering

Indoco Remedies Receives USFDA EIR For Patalganga API Facility

Particology Joins £8.2M Project To Revolutionize API

Lilly Selects Alabama Site as Location for $6 B API Facility

Is biopharma facing a microbial manufacturing crunch?

DCC Backs Separate Licensing for Bulk Drugs and Excipients

Pharma Gains from Rupee's Fall Despite Reliance on APIs

Promoting Indigenous Pharma Manufacturing

Mangalam Drugs Receives Rs. 15 Crore Repeat Export Order

DoP Seeks Applications For PLI Scheme To Produce 2 Bulk Drugs

Moehs visits the UPF

Himachal Drug Cos Under Stop Orders Found Operational

GAO Finds FDA Staffing Shortfalls Delaying Device Recall Work

AICDF Seeks Pharma Prosecution for Decade-Long Non-Compliance

FDA Warns Companies For CGMP Violations, Unapproved Marketing

Merck, Sanofi, AZ Shots For RSV Now Under Scrutiny By FDA

India Pharma Inc Shifts From Compliance To Commitment In Safety

FDA Panel Votes Against J&J Shunt Implant For Heart Failure

USFDA Issues Form 483 With 3 Observations To Ipca's Tarapur Plant

Precipio Identifies Unauthorized Access to Isolated Storage

FDA Official: CDER Warning Letters Up 50% In FY 2025

Sanyou Bio & Kanrybio Partner To Co-Develop Biomarker Assay Kits

Poppins Introduces Pediatric Care Platform For Working Parents

Peijia Medical Gets NMPA Approval For Taurustrio Valve System